scispace - formally typeset
K

Komal Raina

Researcher at South Dakota State University

Publications -  76
Citations -  7826

Komal Raina is an academic researcher from South Dakota State University. The author has contributed to research in topics: Silibinin & Cancer. The author has an hindex of 31, co-authored 64 publications receiving 7085 citations. Previous affiliations of Komal Raina include University of Montana & University of Colorado Boulder.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Chemopreventive Properties of Dietary Rice Bran: Current Status and Future Prospects

TL;DR: The establishment of dietary rice bran as a practical food-derived chemopreventive agent has the potential to have a significant impact on cancer prevention for the global population.
Journal ArticleDOI

Silibinin Inhibits Established Prostate Tumor Growth, Progression, Invasion, and Metastasis and Suppresses Tumor Angiogenesis and Epithelial-Mesenchymal Transition in Transgenic Adenocarcinoma of the Mouse Prostate Model Mice

TL;DR: Overall, silibinin treatment of TRAMP mice bearing prostate tumor inhibited tumor growth, progression, local invasion, and distant metastasis involving suppression of tumor angiogenesis and epithelial-mesenchymal transition and would have greater relevance for the ongoing phase II clinical trial with silib inin-phytosome in prostate cancer patients.
Journal ArticleDOI

Chemopreventive effects of oral gallic acid feeding on tumor growth and progression in TRAMP mice.

TL;DR: It is identified that oral gallic acid feeding inhibits prostate cancer growth and progression to advanced-stage adenocarcinoma in TRAMP mice via a strong suppression of cell cycle progression and cell proliferation and an increase in apoptosis.
Journal ArticleDOI

Growth inhibition and regression of lung tumors by silibinin: modulation of angiogenesis by macrophage-associated cytokines and nuclear factor-kappaB and signal transducers and activators of transcription 3.

TL;DR: Therapeutic efficacy of silibinin in lung tumor growth inhibition and regression by antiangiogenic mechanisms seem to be mediated by decreased tumor-associated macrophages and cytokines, inhibition of hypoxia-inducible factor-1α, NF-κB, and STAT-3 activation, and up-regulation of the angiogenic inhibitors, Ang-2 and Tie-2.